Table 1.
Event rates for primary and secondary outcomes comparing control and COVID-19 period
| Measure | n | Control cohort (n=122) | COVID-19 cohort (n=18) | P-value |
|---|---|---|---|---|
| Mode of anaesthesia, n (%): | 137 | <0.01§ | ||
| GA | 48/119 (40.3%) | 0/18 (0%) | ||
| Epidural top-up | 19/119 (16.0%) | 2/18 (11.1%) | ||
| Spinal | 51/119 (42.9%) | 16/18 (88.9%) | ||
| Spinal to GA conversion | 1/119 (0.8%) | 0/19 (0%) | ||
| RA utilisation, n (%): | 137 | 70/119 (58.8%) | 18/18 (100%) | <0.01§ |
| Overall decision-to-delivery interval, median [IQR], min | 135 | 25 [16–31] | 27.5 [19.8–33.0] | 0.42† |
| Overall theatre-to-delivery interval, median [IQR], min | 134 | 18 [12–24] | 20.0 [14.7–23.3] | 0.47† |
| Neonatal resuscitation, n (%) | 140 | 37 (30.3%) | 4 (22.2%) | 0.48§ |
| Apgar score <7 at 5 min, n (%) | 130 | 10 (8.8%) | 1 (5.8%) | 0.68§ |
| Missing data, n | 9 | 1 | ||
| Neonatal unit admission, n (%) | 140 | 25 (20.4%) | 6 (33.3%) | 0.22§ |
GA: general anaesthesia. RA: regional anaesthesia.
§denotes tests performed using Pearson’s exact statistic, and † denotes tests performed using Wilcoxon rank sum statistic.